Despite an ongoing epidemic of HIV among Thai people who inject drugs, Thailand has failed to implement essential harm reduction programmes. In response, a drug user-led harm reduction centre opened in 2004 in an effort to expand reduction programming in Thailand. The authors examined experiences with the Mitsampan Harm Reduction Centre (MSHRC) among injecting drug users participating in the Mitsampan Community Research Project ( Bangkok). Multivariate logistic regression was used to identify factors associated with Mitsampan Harm Reduction Centre use. Kerr et al also examined services used at and barriers to the Mitsampan Harm Reduction Centre. 252 injecting drug users participated in this study, including 66 (26.2%) females. In total, 74 (29.3%) participants had accessed the Mitsampan Harm Reduction Centre. In multivariate analyses, Mitsampan Harm Reduction Centre use was positively associated with difficulty accessing syringes (Adjusted Odds Ratio [AOR]=4.05; 95% Confidence Interval [CI]: 1.67-9.80), midazolam injection (AOR=3.25; 95%CI: 1.58-6.71), having greater than primary school education (AOR=1.88; 95%CI: 1.01-3.52), and was negatively associated with female gender (AOR=0.20; 95%CI: 0.08-0.50). Forms of support most commonly accessed included: syringe distribution (100%), food and a place to rest (83.8%), HIV education (75.7%), and safer injecting education (66.2%). The primary reason given for not having accessed the Mitsampan Harm Reduction Centre was “didn’t know it existed.” The Mitsampan Harm Reduction Centre is expanding the scope of harm reduction in Thailand by reaching injecting drug users, including those who report difficulty accessing sterile syringes, and by providing various forms of support. In order to maximise its benefits, efforts should be made to increase awareness of the Mitsampan Harm Reduction Centre, in particular among women.
No comments:
Post a Comment